Bio-Rad’s CFX Automation System Enables Walk-Away, High-Throughput Real-Time PCR
News Feb 18, 2010
Bio-Rad Laboratories, Inc., a multinational manufacturer and distributor of life science research and clinical diagnostic products, today announced the availability of the CFX automation system for walk-away, high-throughput qPCR on its CFX96™ and CFX384™ real-time PCR detection systems.
In the pharmaceutical and biopharmaceutical markets, performance, time-to-result, and sample throughput are increasingly important. The addition of the CFX automation system to the CFX96 and CFX384 real-time PCR systems offers a high quality, high-throughput, automated PCR solution for these researchers.
“The time needed to run multiple PCR plates is one of the major bottlenecks in generating real-time PCR data,” said Richard Kurtz, Marketing Manager, Amplification, Bio Rad Laboratories. “The CFX automation platform eliminates the need for a researcher to be present to load the PCR plate and start each run individually. Now all they need to do is load the stacker, setup the runs, and walk away.”
The CFX automation system is equipped with a benchtop plate handler with the capacity to load up to twenty 384-well plates or 7,680 samples at a time on the CFX384 system, facilitating workflow automation, generation of large volumes of data, and rapid analysis of that data.
CFX automation control software manages the configuration and operation of the CFX automation system with one CFX96 or CFX384 real-time PCR detection system, ensuring maximum productivity. Researchers can use the CFX automation control software to define PCR protocols for multiple experiments at once, enabling either the same protocol to be applied across each plate or different protocols for each plate.
No Country for Old GenesNews
Our modern world is radically different from the one we evolved in, and that creates a mismatch between the environment our genes were evolved to face, and the world those genes now encounter. A new review looks at how certain genes that benefited humans in our genetic past now predispose us to disease in old age.READ MORE
CRISPR Editing Stops HIV Virus in Infected CellsNews
Human immunodeficiency virus-1 (HIV-1) infection is a chronic disease affecting more than 35 million people worldwide. The infection can be controlled by antiretroviral therapy (ART), but there is still no complete cure. Now, a new study targeting the regulatory genes of the virus using CRISPR/Cas9 has helped block the production of the virus by infected cells.READ MORE
Genetics Help Make a Weed a WeedNews
A study has has found that the success of weedy and invasive plants like the Jerusalem artichoke lies in their genes. Understanding how invasive plants evolve and the genes that enable them to thrive in a new environment is key to better understanding why they are wreaking havoc on natural landscapes and food production around the world.READ MORE